Skip to content

Clinical trials

Phase 1/2 Uterine Cervical Neoplasms trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Uterine Cervical Neoplasms Phase: Phase 1/2 Country / region: United Kingdom Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20051
20091
20101
20131
20152
20161
20171
20192
20201
20211
20221
20232
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Terminated5
Active, not recruiting4
Recruiting2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cancer Research UK3
Seagen Inc.2
Amgen1
AstraZeneca1
Barts & The London NHS Trust1
Genmab1
Grey Wolf Therapeutics1
Imperial College London1
Incyte Corporation1
Kymab Limited1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Uterine Cervical Neoplasms18
Ovarian Neoplasms8
Carcinoma, Non-Small-Cell Lung6
Endometrial Neoplasms6
Esophageal Neoplasms6
Squamous Cell Carcinoma of Head and Neck6
Pancreatic Neoplasms5
Stomach Neoplasms5
Urinary Bladder Neoplasms5
Neoplasms4

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.